Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review

IF 3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Global Heart Pub Date : 2024-02-20 DOI:10.5334/gh.1299

Diana Sherifali, Lilian Pinto Da Silva, Pooja Dewan, F. Aaysha Cader, Zainab Dakhil, Bishal Gyawali, Sheila Klassen, Israa Fadhil Yaseen, Milos Jovkovic, Saira Khalid, Donna Fitzpatrick-Lewis, Paige Alliston, Megan Racey

{"title":"Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review","authors":"Diana Sherifali, Lilian Pinto Da Silva, Pooja Dewan, F. Aaysha Cader, Zainab Dakhil, Bishal Gyawali, Sheila Klassen, Israa Fadhil Yaseen, Milos Jovkovic, Saira Khalid, Donna Fitzpatrick-Lewis, Paige Alliston, Megan Racey","doi":"10.5334/gh.1299","DOIUrl":null,"url":null,"abstract":"Background: Although there is evidence of peer support in high-income countries, the use of peer support as an intervention for cardiometabolic disease management, including type 2 diabetes (T2DM), in low- and middle-income countries (LMICs), is unclear. Methods: A scoping review methodology was used to search the databases MEDLINE, Embase, Emcare, PsycINFO, LILACS, CDSR, and CENTRAL. Results: Twenty-eight studies were included in this scoping review. Of these, 67% were developed in Asia, 22% in Africa, and 11% in the Americas. The definition of peer support varied; however, peer support offered a social and emotional dimension to help individuals cope with negative emotions and barriers while promoting disease management. Conclusions: Findings from this scopingreview highlight a lack of consistency in defining peer support as a component of CMD management in LMICs. A clear definition of peer support and ongoing program evaluation is recommended for future research.","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"232 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Heart","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5334/gh.1299","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Although there is evidence of peer support in high-income countries, the use of peer support as an intervention for cardiometabolic disease management, including type 2 diabetes (T2DM), in low- and middle-income countries (LMICs), is unclear. Methods: A scoping review methodology was used to search the databases MEDLINE, Embase, Emcare, PsycINFO, LILACS, CDSR, and CENTRAL. Results: Twenty-eight studies were included in this scoping review. Of these, 67% were developed in Asia, 22% in Africa, and 11% in the Americas. The definition of peer support varied; however, peer support offered a social and emotional dimension to help individuals cope with negative emotions and barriers while promoting disease management. Conclusions: Findings from this scopingreview highlight a lack of consistency in defining peer support as a component of CMD management in LMICs. A clear definition of peer support and ongoing program evaluation is recommended for future research.

查看原文本刊更多论文

中低收入国家（LMICs）2 型糖尿病管理的同伴支持：范围审查

背景：尽管在高收入国家有同伴支持的证据，但在中低收入国家（LMICs）将同伴支持作为包括 2 型糖尿病（T2DM）在内的心脏代谢疾病管理干预措施的使用情况尚不清楚。研究方法采用范围综述的方法检索了 MEDLINE、Embase、Emcare、PsycINFO、LILACS、CDSR 和 CENTRAL 等数据库。结果本次范围界定审查共纳入 28 项研究。其中，67%的研究在亚洲开展，22%在非洲开展，11%在美洲开展。同伴支持的定义各不相同；但是，同伴支持提供了一个社会和情感维度，帮助个人应对负面情绪和障碍，同时促进疾病管理。结论：本次范围界定研究的结果突出表明，在低收入与中等收入国家，将同伴支持定义为慢性阻塞性肺病管理的一个组成部分缺乏一致性。建议在今后的研究中对同伴支持进行明确定义并持续开展项目评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Global Heart Medicine-Cardiology and Cardiovascular Medicine

CiteScore

5.70

自引率

5.40%

发文量

审稿时长

5 weeks

期刊介绍： Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources. Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention. Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.